Vanessa Caceres

Rheumatoid arthritis patients who have had a malignancy and are receiving a TNFi or rituximab (RTX), do not appear to have an increased risk of cancer recurrence.

Brief report in the journal Arthritis Care and Research shows that patients report favorable outcomes with a tofacitinib/DMARD combo therapy.

Some patients are not being screened or treated for glucocorticoid-induced osteoporosis by primary care physicians or rheumatologists.

Treg cells are more prevalent in patients with juvenile idiopathic arthritis and active inflammation, as compared to patients in remission.

Rheumatoid arthritis patients are inherently at higher risk of melanoma, but a new study shows that biologics do not increase that risk.

EULAR 2016: Patient education and compliance often take a back seat to disease management, but they need to be at the forefront of care.

EULAR 2016: Ixekizumab significantly helped signs and symptoms of psoriatic arthritis in a phase 3 study reported this week.

Rheumatoid arthritis and periodontitis seem to be related, shows a new study that also highlights other commonalities between the two diseases.

There are several known risk factors and "red flags" that should prompt clinicians to suspect nonalcoholic steatohepatitis or nonalcoholic fatty liver disease and conduct appropriate testing.

The recently approved antivirals boast improved rates of sustained virologic response and fewer, less-severe side effects compared with older treatments.

Clinicians should be familiar with all current testing options and assessment tools and be prepared to offer support and guidance to patients who may be embarrassed or unwilling to discuss this aspect of their health.

Despite many technological advances, better training and education are the most important factors to boost the detection of adenomas in the colon and reduce interval colorectal cancer.

Without proper assessment and treatment, a patient with mild colitis or Crohn's disease can easily transition into more severe disease.

With renewed attention on maximizing return on every dollar spent on health care, gastroenterologists need to take a thoughtful approach that takes cost and the overall patient experience into account when they make testing and treatment decisions with patients who have inflammatory bowel disease.

Polyethylene glycol in conjunction with fiber supplementation is an effective treatment for occasional constipation in patients with irritable bowel syndrome.

With fecal microbiota transplantation, patients with recurrent C. difficile infection can avoid prolonged, repeated courses of antibiotics. The procedure can also help to re-establish normal intestinal microbiome diversity, assisting patients in restoring colonization resistance.